跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Axbin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Axbin
Approved
STANDARD
Axbin
Korea United Pharm. Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1f5dbd07dd45057e
Company
Korea United Pharm. Inc.
Type
Standard
Approval Details
Approval Id
1f5dbd07dd45057e
Drug Approval Philippines Name
Axbin
Product Name
Axbin
Registration Number
DR-XY49223
Brand Name
Axbin
Generic Name
Doxorubicin hydrochloride
Dosage Form
Lyophilized Powder for Injection (I.V.)
Dosage Strength
50 mg
Manufacturer
Korea United Pharm. Inc.
Importer
Qualimed Pharma Inc.
Distributor
Qualimed Pharma Inc.
Company Detail Path
/organization/korea-united-pharm-inc
Issuance Date
24 September 2024
Expiry Date
24 September 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1f5dbd07dd45057e
Type
Standard
Back to Philippines FDA Approvals